These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 4955716)
1. [On some biological effects of the cytostatic agent verrucarin A]. Rüsch ME; Stähelin H Arzneimittelforschung; 1965 Aug; 15(8):893-7. PubMed ID: 4955716 [No Abstract] [Full Text] [Related]
2. [Methodical aspects in studies on the carcinogenesis and chemotherapy of tumors]. Schmähl D Planta Med; 1968; ():3-12. PubMed ID: 4976078 [No Abstract] [Full Text] [Related]
3. [Experimental methodology for the selection of potential anticancer agents]. Pérez Mínguez F; Llombart Bosch A Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacological studies on bimolane (AT-1727), a new antineoplastic agent (author's transl)]. Zhang TM; Chen ZY; Lin C Yao Xue Xue Bao; 1980 Oct; 15(10):577-83. PubMed ID: 7257778 [No Abstract] [Full Text] [Related]
5. [Segidrin: a new-type antineoplastic agent]. Filov VA Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790 [No Abstract] [Full Text] [Related]
7. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations. Institóris L; Horváth IP; Csányi E Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481 [No Abstract] [Full Text] [Related]
8. [Toxicity and antineoplastic activity of pyrimidylamidophosphodiethylene imides as a function of their chemical structure]. Chernov VA; Garibdzhanian BT Farmakol Toksikol; 1965; 28(3):340-5. PubMed ID: 5869653 [No Abstract] [Full Text] [Related]
9. [Methods of testing substances for cytostatic effectiveness]. Gericke D Munch Med Wochenschr; 1973 May; 115(18):833-8. PubMed ID: 4800215 [No Abstract] [Full Text] [Related]
10. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours. Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384 [No Abstract] [Full Text] [Related]
11. [Sizofilan]. Furue H Gan To Kagaku Ryoho; 1986 Dec; 13(12):3549-52. PubMed ID: 2947540 [No Abstract] [Full Text] [Related]
12. [ACPA (1-aminocyclopentanol-1-carboxylic acid) as an antitumor agent]. Minenkova EA; Vermel' EM Vopr Onkol; 1967; 13(2):93-9. PubMed ID: 5245210 [No Abstract] [Full Text] [Related]
13. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXVI. Plant extracts. Abbott BJ; Hartwell JL; Iltis HH; Kupchan SM; Leiter J; Perdue RE; Schepartz SA Cancer Res; 1966 Sep; 26(9 Pt 2):1131-271. PubMed ID: 5212555 [No Abstract] [Full Text] [Related]
14. Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor, U-15,774. Evans JS; Gerritsen GC; Mann KM; Owen SP Cancer Chemother Rep; 1965 Oct; 48():1-6. PubMed ID: 4953644 [No Abstract] [Full Text] [Related]
15. [Studies on the antineoplastic action and toxicity of synthetic indirubin (author's transl)]. Ji XJ; Zhang FR; Lei JL; Xu YT Yao Xue Xue Bao; 1981 Feb; 16(2):146-8. PubMed ID: 7304182 [No Abstract] [Full Text] [Related]
16. [Study of the cytostatic action of an alpha-glyceryl-ether on T 8 carcinoma in rats]. Delmon G; Biraben J C R Seances Soc Biol Fil; 1966; 160(1):76-7. PubMed ID: 4286966 [No Abstract] [Full Text] [Related]
17. [The pharmacological properties of preparations from the aziridinyl triazine group]. Stukov AN; Filov VA; Kon'kov SA; Ivin BA Eksp Klin Farmakol; 1996; 59(1):58-60. PubMed ID: 8704637 [TBL] [Abstract][Full Text] [Related]